X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (662) 662
Publication (150) 150
Dissertation (7) 7
Book Review (5) 5
Newspaper Article (5) 5
Book / eBook (4) 4
Newsletter (4) 4
Magazine Article (2) 2
Book Chapter (1) 1
Conference Proceeding (1) 1
Paper (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (431) 431
hematology (336) 336
index medicus (282) 282
female (238) 238
male (229) 229
oncology (224) 224
middle aged (216) 216
adult (203) 203
aged (160) 160
treatment outcome (117) 117
chemotherapy (102) 102
prognosis (90) 90
adolescent (89) 89
article (88) 88
acute myeloid-leukemia (87) 87
remission induction (86) 86
antineoplastic agents - therapeutic use (82) 82
cancer (82) 82
antineoplastic combined chemotherapy protocols - therapeutic use (80) 80
therapy (80) 80
trans-retinoic acid (77) 77
aged, 80 and over (69) 69
abridged index medicus (68) 68
acute myelogenous leukemia (68) 68
acute promyelocytic leukemia (68) 68
leukemia (67) 67
leukemia, promyelocytic, acute - drug therapy (67) 67
young adult (63) 63
transplantation (59) 59
survival analysis (57) 57
acute myeloid leukemia (52) 52
animals (52) 52
leukemia, myeloid, acute - drug therapy (52) 52
arsenic trioxide (49) 49
disease-free survival (49) 49
mutation (47) 47
recurrence (46) 46
survival rate (43) 43
leukemia, myeloid, acute - genetics (42) 42
stem-cell transplantation (41) 41
tretinoin - therapeutic use (40) 40
minimal residual disease (38) 38
research (38) 38
hemic and lymphatic diseases (37) 37
remission (37) 37
bone-marrow-transplantation (36) 36
survival (36) 36
acute disease (34) 34
hematology, oncology and palliative medicine (34) 34
hematopoietic stem cell transplantation (34) 34
immunology (33) 33
antineoplastic agents - adverse effects (32) 32
child (32) 32
leukemia, myeloid, acute - therapy (32) 32
retrospective studies (32) 32
risk factors (32) 32
analysis (31) 31
expression (31) 31
time factors (31) 31
trial (31) 31
aml (30) 30
follow-up studies (30) 30
relapse (29) 29
adults (28) 28
care and treatment (28) 28
health aspects (28) 28
leukemia, myeloid, acute - mortality (28) 28
biochemistry & molecular biology (27) 27
leukemia, promyelocytic, acute - mortality (27) 27
mice (27) 27
antineoplastic combined chemotherapy protocols - adverse effects (26) 26
clinical trials as topic (26) 26
cytarabine - administration & dosage (26) 26
child, preschool (25) 25
cladribine - therapeutic use (25) 25
clinical trials and observations (25) 25
clinical trials (24) 24
complete remission (24) 24
cytogenetics (24) 24
transplantation, homologous (24) 24
arsenicals - therapeutic use (23) 23
leukemia, myeloid, acute - diagnosis (23) 23
2-chlorodeoxyadenosine (22) 22
consolidation (22) 22
daunorubicin - administration & dosage (22) 22
differentiation (22) 22
hematopoietic stem cells (22) 22
oxides - therapeutic use (22) 22
risk (22) 22
genetic aspects (21) 21
leukemia, promyelocytic, acute - pathology (21) 21
myelodysplastic syndrome (21) 21
acute lymphoblastic-leukemia (20) 20
gemtuzumab ozogamicin (20) 20
medicine, general & internal (20) 20
mutations (20) 20
tretinoin - adverse effects (20) 20
cells (19) 19
hematopoietic stem cell transplantation - methods (19) 19
induction chemotherapy (19) 19
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Analytical Biochemistry, ISSN 0003-2697, 02/2019, Volume 566, pp. 89 - 101
Isolevuglandins (IsoLGs) are a family of highly reactive 4-ketoaldehydes formed by lipid peroxidation that modify the lysyl residues of cellular proteins.... 
LC/MS | Lipid peroxidation | Protein adducts | Post-translational modifications | Isolevuglandins | Aldehydes | OXIDATION | CELLS | CHEMISTRY, ANALYTICAL | REACTIVE GAMMA-KETOALDEHYDES | BIOCHEMISTRY & MOLECULAR BIOLOGY | BIOCHEMICAL RESEARCH METHODS | PRODUCTS
Journal Article
CURRENT OPINION IN HEMATOLOGY, ISSN 1065-6251, 03/2018, Volume 25, Issue 2, pp. 60 - 60
Journal Article
CURRENT OPINION IN HEMATOLOGY, ISSN 1065-6251, 03/2016, Volume 23, Issue 2
Journal Article
Blood, ISSN 0006-4971, 01/2016, Volume 127, Issue 1, pp. 71 - 78
Journal Article
Seminars in Hematology, ISSN 0037-1963, 04/2019, Volume 56, Issue 2, pp. 83 - 83
Journal Article
by Tefferi, Ayalew, MD and Kantarjian, Hagop, MD and Rajkumar, S. Vincent, MD and Baker, Lawrence H., DO and Abkowitz, Jan L., MD and Adamson, John W., MD and Advani, Ranjana Hira, MD and Allison, James, MD and Antman, Karen H., MD and Bast, Robert C., MD and Bennett, John M., MD and Benz, Edward J., MD and Berliner, Nancy, MD and Bertino, Joseph, MD and Bhatia, Ravi, MD and Bhatia, Smita, MD and Bhojwani, Deepa, MD and Blanke, Charles D., MD and Bloomfield, Clara D., MD and Bosserman, Linda, MD and Broxmeyer, Hal E., PhD and Byrd, John C., MD and Cabanillas, Fernando, MD and Canellos, George Peter, MD and Chabner, Bruce A., MD and Chanan-Khan, Asher, MD and Cheson, Bruce, MD and Clarkson, Bayard, MD and Cohn, Susan L., MD and Colon-Otero, Gerardo, MD and Cortes, Jorge, MD and Coutre, Steven, MD and Cristofanilli, Massimo, MD and Curran, Walter J., MD and Daley, George Q., MD, PhD and DeAngelo, Daniel J., MD, PhD and Deeg, H. Joachim, MD and Einhorn, Lawrence H., MD and Erba, Harry P., MD, PhD and Esteva, Francisco J., MD, PhD and Estey, Elihu, MD and Fidler, Isaiah J., DVM, PhD and Foran, James, MD and Forman, Stephen, MD and Freireich, Emil, MD and Fuchs, Charles, MD, MPH and George, James N., MD and Gertz, Morie A., MD and Giralt, Sergio, MD and Golomb, Harvey, MD and Greenberg, Peter, MD and Gutterman, Jordan, MD and Handin, Robert I., MD and Hellman, Samuel, MD and Hoff, Paulo Marcelo, MD and Hoffman, Ronald, MD and Hong, Waun Ki, MD and Horowitz, Mary, MD, MS and Hortobagyi, Gabriel N., MD and Hudis, Clifford, MD and Issa, Jean Pierre, MD and Johnson, Bruce Evan, MD and Kantoff, Philip W., MD and Kaushansky, Kenneth, MD and Khayat, David, MD, PhD and Khuri, Fadlo R., MD and Kipps, Thomas J., MD, PhD and Kripke, Margaret, PhD and Kyle, Robert A., MD and Larson, Richard A., MD and Lawrence, Theodore S., MD, PhD and Levine, Ross, MD and Link, Michael P., MD and Lippman, Scott M., MD and Lonial, Sagar, MD and Lyman, Gary H., MD, MPH and Markman, Maurie, MD and Mendelsohn, John, MD and Meropol, Neal J., MD and Messinger, Yoav, MD and Mulvey, Therese M., MD and O’Brien, Susan, MD and Perez-Soler, Roman, MD and Pollock, Raphael, MD, PhD and Prchal, Josef, MD and Press, Oliver, MD, PhD and Radich, Jerald, MD and Rai, Kanti, MD and Rosenberg, Saul A., MD and Rowe, Jacob M., MD and Rugo, Hope, MD and Runowicz, Carolyn D., MD and Sandmaier, Brenda M., MD and Saven, Alan, MD and Schafer, Andrew I., MD and Schiffer, Charles, MD and Sekeres, Mikkael A., MD, MS and Silver, Richard T., MD and Siu, Lillian L., MD and Steensma, David P., MD and ...
Mayo Clinic Proceedings, ISSN 0025-6196, 2015, Volume 90, Issue 8, pp. 996 - 1000
Journal Article
CURRENT OPINION IN HEMATOLOGY, ISSN 1065-6251, 03/2014, Volume 21, Issue 2, pp. V - V
Journal Article
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, ISSN 1521-6926, 03/2014, Volume 27, Issue 1, pp. 1 - 1
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 5, pp. 454 - 464
Midostaurin, an oral multitargeted kinase inhibitor, is active in patients with a FLT3 mutation. Among patients with acute myeloid leukemia and this mutation,... 
TRIAL | INTERNAL TANDEM DUPLICATION | WILD-TYPE | MEDICINE, GENERAL & INTERNAL | FAVORABLE PROGNOSIS | ACUTE MYELOGENOUS LEUKEMIA | DISTINCT | TYROSINE KINASE INHIBITOR | SORAFENIB | PHASE-I | YOUNGER | Humans | Middle Aged | Kaplan-Meier Estimate | Staurosporine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Staurosporine - analogs & derivatives | Protein Kinase Inhibitors - adverse effects | Cytarabine - administration & dosage | Leukemia, Myeloid, Acute - mortality | Young Adult | fms-Like Tyrosine Kinase 3 - genetics | Protein Kinase Inhibitors - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Mutation | Daunorubicin - administration & dosage | Leukemia, Myeloid, Acute - genetics | Staurosporine - administration & dosage | Chemotherapy | Care and treatment | Myelocytic leukemia | Nonlymphoid leukemia | Research | Drug therapy | Cancer | Tyrosine | Medical research | Inhibitor drugs | Myeloid leukemia | Leukemia | Clinical trials | Oncology | Transplantation | Kinases | Patients | Cancer therapies | Survival | Cytarabine | Daunorubicin | Medical prognosis | Point mutation | Death | Remission | Acute myeloid leukemia | Protein-tyrosine kinase | Drug dosages
Journal Article
Journal Article